Active surveillance criteria for prostate cancer: Can they be applied to Japanese patients?
暂无分享,去创建一个
Y. Kakuta | Hiroyoshi Suzuki | Naoki Hasegawa | Atsushi Inoue | K. Nozumi | K. Miyazaki | A. Matsumoto | M. Nagata | Hiroki Kito | Kunio Yamaguchi | Yusuke Goto
[1] M. Kattan,et al. Predicting 15-year prostate cancer specific mortality after radical prostatectomy. , 2011, The Journal of urology.
[2] H. Yasunaga,et al. Updated Japanese Urological Association Guidelines on prostate‐specific antigen‐based screening for prostate cancer in 2010 , 2010, International journal of urology : official journal of the Japanese Urological Association.
[3] B. G. Blijenberg,et al. Screening and prostate-cancer mortality in a randomized European study. , 2009, The New England journal of medicine.
[4] P. Carroll,et al. Pathological outcomes of candidates for active surveillance of prostate cancer. , 2009, The Journal of urology.
[5] M. Cooperberg,et al. Active surveillance for the management of prostate cancer in a contemporary cohort , 2008, Cancer.
[6] S. Fukuhara,et al. Prospective evaluation of selection criteria for active surveillance in Japanese patients with stage T1cN0M0 prostate cancer. , 2008, Japanese journal of clinical oncology.
[7] R. V. D. van den Bergh,et al. Prospective validation of active surveillance in prostate cancer: the PRIAS study. , 2007, European urology.
[8] E. Metter,et al. Expectant management of prostate cancer with curative intent: an update of the Johns Hopkins experience. , 2007, The Journal of urology.
[9] M. Terris,et al. Upgrading and downgrading of prostate needle biopsy specimens: risk factors and clinical implications. , 2006, Urology.
[10] Lisa M. Schwartz,et al. Screening men for prostate and colorectal cancer in the United States: does practice reflect the evidence? , 2003, JAMA.
[11] Liying Zhang,et al. Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.